178 related articles for article (PubMed ID: 35386697)
21. Improving anticancer effect of aPD-L1 through lowering neutrophil infiltration by PLAG in tumor implanted with MB49 mouse urothelial carcinoma.
Kim GT; Kim EY; Shin SH; Lee H; Lee SH; Sohn KY; Kim JW
BMC Cancer; 2022 Jul; 22(1):727. PubMed ID: 35787261
[TBL] [Abstract][Full Text] [Related]
22. High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.
Wang B; Liu H; Dong X; Wu S; Zeng H; Liu Z; Wan D; Dong W; He W; Chen X; Zheng L; Huang J; Lin T
Oncotarget; 2015 Aug; 6(24):20204-14. PubMed ID: 26001293
[TBL] [Abstract][Full Text] [Related]
23. Chitinase 3-like 1 expression associated with lymphatic metastasis and prognosis in urothelial carcinoma of the bladder.
Wang B; Chen K; Gao M; Sun X; He W; Chen J; Yang W; Yang T; Qin H; Ruan H; Huang H; Lin T; Huang J
Clin Transl Immunology; 2024; 13(4):e1505. PubMed ID: 38623539
[TBL] [Abstract][Full Text] [Related]
24. PD-L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer.
Miller TJ; Anyaegbu CC; Lee-Pullen TF; Spalding LJ; Platell CF; McCoy MJ
Cancer Sci; 2021 Mar; 112(3):1173-1183. PubMed ID: 33345422
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
[TBL] [Abstract][Full Text] [Related]
26. Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis.
Tang D; Zhang D; Heng Y; Zhu XK; Lin HQ; Zhou J; Tao L; Lu LM
J Inflamm Res; 2022; 15():1079-1097. PubMed ID: 35210813
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
[TBL] [Abstract][Full Text] [Related]
29. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
Xylinas E; Robinson BD; Kluth LA; Volkmer BG; Hautmann R; Küfer R; Zerbib M; Kwon E; Thompson RH; Boorjian SA; Shariat SF
Eur J Surg Oncol; 2014 Jan; 40(1):121-7. PubMed ID: 24140000
[TBL] [Abstract][Full Text] [Related]
30. Identification of an IDO1-based immune classifier for survival prediction of upper tract urothelial carcinoma.
Zhong W; Yang M; Cheng S; Hou W; Wang B; Chen J; Yu H; Ouyang Y; Wang X; Ou Z; Xu P; Li X; Zhou L; Huang J; Wang C; Lin T
Cancer Sci; 2022 Mar; 113(3):852-863. PubMed ID: 34962030
[TBL] [Abstract][Full Text] [Related]
31. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
Inman BA; Sebo TJ; Frigola X; Dong H; Bergstralh EJ; Frank I; Fradet Y; Lacombe L; Kwon ED
Cancer; 2007 Apr; 109(8):1499-505. PubMed ID: 17340590
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
33. Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.
Deng H; Kan A; Lyu N; He M; Huang X; Qiao S; Li S; Lu W; Xie Q; Chen H; Lai J; Chen Q; Jiang X; Liu S; Zhang Z; Zhao M
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34168004
[TBL] [Abstract][Full Text] [Related]
34. The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
Wen Y; Chen Y; Duan X; Zhu W; Cai C; Deng T; Zeng G
Clin Exp Med; 2019 Nov; 19(4):407-416. PubMed ID: 31407099
[TBL] [Abstract][Full Text] [Related]
35. A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer.
Flores-Martín JF; Perea F; Exposito-Ruiz M; Carretero FJ; Rodriguez T; Villamediana M; Ruiz-Cabello F; Garrido F; Cózar-Olmo JM; Aptsiauri N
Ann Surg Oncol; 2019 Aug; 26(8):2631-2639. PubMed ID: 31011905
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder.
Owyong M; Lotan Y; Kapur P; Panwar V; McKenzie T; Lee TK; Zi X; Martin JW; Mosbah A; Abol-Enein H; Ghoneim M; Youssef RF
Urol Oncol; 2019 Jul; 37(7):478-484. PubMed ID: 30910351
[TBL] [Abstract][Full Text] [Related]
37. PD-L1
Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q
Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709
[No Abstract] [Full Text] [Related]
38. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
Zhu L; Liu X; Zhang W; Hu H; Wang Q; Xu K
BMC Cancer; 2022 May; 22(1):556. PubMed ID: 35581573
[TBL] [Abstract][Full Text] [Related]
39. The Interplay Between Neutrophils and CD8
Governa V; Trella E; Mele V; Tornillo L; Amicarella F; Cremonesi E; Muraro MG; Xu H; Droeser R; Däster SR; Bolli M; Rosso R; Oertli D; Eppenberger-Castori S; Terracciano LM; Iezzi G; Spagnoli GC
Clin Cancer Res; 2017 Jul; 23(14):3847-3858. PubMed ID: 28108544
[No Abstract] [Full Text] [Related]
40. Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy.
Li XD; Huang CW; Liu ZF; Jiang LJ; Chen JW; Xie D; Zhou FJ; Lu HM; Liu ZW
Ann Surg Oncol; 2019 Nov; 26(12):4148-4156. PubMed ID: 31376036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]